149 related articles for article (PubMed ID: 33094962)
21. Prognosis of patients with superficial T1 esophageal cancer who underwent endoscopic resection before esophagectomy-A propensity score-matched comparison.
Plum PS; Hölscher AH; Pacheco Godoy K; Schmidt H; Berlth F; Chon SH; Alakus H; Bollschweiler E
Surg Endosc; 2018 Sep; 32(9):3972-3980. PubMed ID: 29536160
[TBL] [Abstract][Full Text] [Related]
22. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus.
Altorki N; Kent M; Ferrara C; Port J
Ann Surg; 2002 Aug; 236(2):177-83. PubMed ID: 12170022
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis.
Porte H; Triboulet JP; Kotelevets L; Carrat F; Prévot S; Nordlinger B; DiGioia Y; Wurtz A; Comoglio P; Gespach C; Chastre E
Clin Cancer Res; 1998 Jun; 4(6):1375-82. PubMed ID: 9626453
[TBL] [Abstract][Full Text] [Related]
24. The impact of the number of occult metastatic lymph nodes on postoperative relapse of resectable esophageal cancer.
Morimoto J; Tanaka H; Ohira M; Kubo N; Muguruma K; Sakurai K; Yamashita Y; Maeda K; Sawada T; Hirakawa K
Dis Esophagus; 2014 Jan; 27(1):63-71. PubMed ID: 23480452
[TBL] [Abstract][Full Text] [Related]
25. Smad4 loss in esophageal adenocarcinoma is associated with an increased propensity for disease recurrence and poor survival.
Singhi AD; Foxwell TJ; Nason K; Cressman KL; McGrath KM; Sun W; Bahary N; Zeh HJ; Levy RM; Luketich JD; Davison JM
Am J Surg Pathol; 2015 Apr; 39(4):487-95. PubMed ID: 25634752
[TBL] [Abstract][Full Text] [Related]
26. Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease.
Schölvinck D; Künzli H; Meijer S; Seldenrijk K; van Berge Henegouwen M; Bergman J; Weusten B
Surg Endosc; 2016 Sep; 30(9):4102-13. PubMed ID: 27357927
[TBL] [Abstract][Full Text] [Related]
27. Early esophageal cancer in Europe: endoscopic treatment by endoscopic submucosal dissection.
Probst A; Aust D; Märkl B; Anthuber M; Messmann H
Endoscopy; 2015 Feb; 47(2):113-21. PubMed ID: 25479563
[TBL] [Abstract][Full Text] [Related]
28. Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence.
Ueda M; Iguchi T; Masuda T; Nakahara Y; Hirata H; Uchi R; Niida A; Momose K; Sakimura S; Chiba K; Eguchi H; Ito S; Sugimachi K; Yamasaki M; Suzuki Y; Miyano S; Doki Y; Mori M; Mimori K
Oncotarget; 2016 Sep; 7(38):62280-62291. PubMed ID: 27556701
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms of Genes Related to Function and Metabolism of Vitamin D in Esophageal Adenocarcinoma.
Singhal S; Kapoor H; Subramanian S; Agrawal DK; Mittal SK
J Gastrointest Cancer; 2019 Dec; 50(4):867-878. PubMed ID: 30187205
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of IgG4+ plasma cell infiltrates following neoadjuvant chemoradiation therapy for esophageal adenocarcinoma.
Yakirevich E; Lu S; Allen D; Mangray S; Fanion JR; Lombardo KA; Safran H; Resnick MB
Hum Pathol; 2017 Aug; 66():126-135. PubMed ID: 28666927
[TBL] [Abstract][Full Text] [Related]
31. Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy.
Nigro JJ; DeMeester SR; Hagen JA; DeMeester TR; Peters JH; Kiyabu M; Campos GM; Oberg S; Gastal O; Crookes PF; Bremner CG
J Thorac Cardiovasc Surg; 1999 May; 117(5):960-8. PubMed ID: 10220691
[TBL] [Abstract][Full Text] [Related]
32. Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome.
Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
Ann Surg; 2007 Jul; 246(1):1-8. PubMed ID: 17592282
[TBL] [Abstract][Full Text] [Related]
33. Local recurrence after total or subtotal esophagectomy for esophageal cancer.
Blewett CJ; Miller JD; Ramlawi B; Young JE; BennettWF ; Urschel JD
J Exp Clin Cancer Res; 2001 Mar; 20(1):17-9. PubMed ID: 11370823
[TBL] [Abstract][Full Text] [Related]
34. Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy.
Findlay JM; Castro-Giner F; Makino S; Rayner E; Kartsonaki C; Cross W; Kovac M; Ulahannan D; Palles C; Gillies RS; MacGregor TP; Church D; Maynard ND; Buffa F; Cazier JB; Graham TA; Wang LM; Sharma RA; Middleton M; Tomlinson I
Nat Commun; 2016 Apr; 7():11111. PubMed ID: 27045317
[TBL] [Abstract][Full Text] [Related]
35. LKB1 inactivation occurs in a subset of esophageal adenocarcinomas and is sufficient to drive tumor cell proliferation.
Whitsett TG; Mittal SK; Eschbacher JM; Carson VM; Smith MA; Bremner RM; Inge LJ
J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1891-1899. PubMed ID: 29370903
[TBL] [Abstract][Full Text] [Related]
36. Outcomes after endoscopic mucosal resection or esophagectomy for submucosal esophageal adenocarcinoma.
Nelson DB; Dhupar R; Katkhuda R; Correa A; Goltsov A; Maru D; Sepesi B; Antonoff MB; Mehran RJ; Rice DC; Vaporciyan AA; Davila M; Davila R; Betancourt S; Ajani J; Hofstetter WL
J Thorac Cardiovasc Surg; 2018 Jul; 156(1):406-413.e3. PubMed ID: 29605441
[TBL] [Abstract][Full Text] [Related]
37. Adverse prognostic impact of intratumor heterogeneous HER2 gene amplification in patients with esophageal adenocarcinoma.
Yoon HH; Shi Q; Sukov WR; Lewis MA; Sattler CA; Wiktor AE; Wu TT; Diasio RB; Jenkins RB; Sinicrope FA
J Clin Oncol; 2012 Nov; 30(32):3932-8. PubMed ID: 22987085
[TBL] [Abstract][Full Text] [Related]
38. Postoperative complications after esophagectomy for adenocarcinoma of the esophagus are related to timing of death due to recurrence.
Lagarde SM; de Boer JD; ten Kate FJ; Busch OR; Obertop H; van Lanschot JJ
Ann Surg; 2008 Jan; 247(1):71-6. PubMed ID: 18156925
[TBL] [Abstract][Full Text] [Related]
39. Complex structural rearrangements are present in high-grade dysplastic Barrett's oesophagus samples.
Newell F; Patel K; Gartside M; Krause L; Brosda S; Aoude LG; Loffler KA; Bonazzi VF; Patch AM; Kazakoff SH; Holmes O; Xu Q; Wood S; Leonard C; Lampe G; Lord RV; Whiteman DC; Pearson JV; Nones K; Waddell N; Barbour AP
BMC Med Genomics; 2019 Feb; 12(1):31. PubMed ID: 30717762
[TBL] [Abstract][Full Text] [Related]
40. Targeted Single Gene Mutation in Esophageal Adenocarcinoma.
Lee KTW; Smith RA; Gopalan V; Lam AK
Methods Mol Biol; 2018; 1756():213-229. PubMed ID: 29600373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]